Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia—a case report

[1] Kuroda S(2008)Moyamoya disease: current concepts and future perspectives Lancet Neurol 7 1056-1066

[2] Houkin K(1969)Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain Arch Neurol 20 288-299

[3] Suzuki J(2014)Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult moyamoya trial Stroke 45 1415-1421

[4] Takaku A(2009)Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2386-2393

[5] Miyamoto S(2012)Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center Pediatr Int 54 524-527

[6] Yoshimoto T(2009)The ITP syndrome: pathogenic and clinical diversity Blood 113 6511-6521

[7] Hashimoto N(2011)The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Blood 117 4190-4207

[8] Okada Y(2012)Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) Neurol Med Chir (Tokyo) 52 245-266

[9] Tsuji I(2010)Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome Neurosurgery 66 1093-1101

[10] Tominaga T(2004)Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP Blood 103 1364-1369

[1] Kuroda S(2008)Moyamoya disease: current concepts and future perspectives Lancet Neurol 7 1056-1066

[2] Houkin K(1969)Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain Arch Neurol 20 288-299

[3] Suzuki J(2014)Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult moyamoya trial Stroke 45 1415-1421

[4] Takaku A(2009)Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2386-2393

[5] Miyamoto S(2012)Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center Pediatr Int 54 524-527

[6] Yoshimoto T(2009)The ITP syndrome: pathogenic and clinical diversity Blood 113 6511-6521

[7] Hashimoto N(2011)The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Blood 117 4190-4207

[8] Okada Y(2012)Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) Neurol Med Chir (Tokyo) 52 245-266

[9] Tsuji I(2010)Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome Neurosurgery 66 1093-1101

[10] Tominaga T(2004)Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP Blood 103 1364-1369